SDC1 and neoplasm: A novel mechanistic pathway driven by heparanase expression in myeloma cells can induce elevated levels of VEGF and shedding of syndecan-1 from matrix-anchored complexes that together activate integrin and VEGF receptors on adjacent endothelial cells, thereby stimulating tumor angiogenesis [38].